ANXIETY AND ANGINA PECTORIS
- Contemporary Management of Angina: Part II. Medical Management of Chronic Stable Angina. Zanger, Diane R.; Solomon, Allen J. // American Family Physician;1/1/2000, Vol. 61 Issue 1, p129
Part II. Provides information on the contemporary medical management of chronic stable angina pectoris. Measures for eliminating risk factors of angina; List of antianginal agents.
- EECP. // Mayo Clinic Health Letter;Oct2001, Vol. 19 Issue 10, p4
Focuses on the use of enhanced external counterpulsation (EECP) for the nonsurgical therapy of angina pectoris caused by narrowed or obstructed coronary arteries. Symptoms of chest pain; Steps in EECP therapy; Theories behind the chest pain relief in EECP; Risk factors of chest pain. INSET:...
- Propranolol in the Office Treatment of Angina Pectoris. HARLEY, B. J. S.; DAVIES, R. O. // Canadian Medical Association Journal;9/21/1968, Vol. 99 Issue 11, p527
The article discusses a study on the value of propranolol versus placebo in the treatment of angina pectoris. Propranolol affect the heart muscle by decreasing cardiac rate and output, as well as reduce oxygen consumption and cardiac work. Fourteen patients were enrolled in the study and most...
- Nitrocine. // Royal Society of Medicine: Medicines;2002, p394
This article presents information on the drug Nitrocine, which is a proprietary, prescription-only preparation of the drug glyceryl trinitrate. Nitrocine can be used as a treatment and or as a preventive measure against cases of angina pectoris. The drug is readily available in the form of an...
- ISOSORBIDE. // Davis's Drug Guide for Nurses, 9th edition;2005, p572
Provides information on isosorbide, an antianginal agent used for the treatment of anginal attacks and angina pectoris. Therapeutic effects; Pharmacokinetics; Contraindications and precautions; Adverse reactions and side effects; Availability.
- Nicorandil in angina: a favourable economic impact. // PharmacoEconomics & Outcomes News;7/15/2006, Issue 507, p1
Discusses research being done on the addition of nicorandil to usual angina pectoris treatment. Reference to a study by A. Walker et al, in the May 2006 issue of "Heart"; Benefits from the added nicorandil; Cost of nicorandil.
- Medical management of chronic stable angina. Yong Wee; Burns, Kylie; Bett, Nicholas // Australian Prescriber;Aug2015, Vol. 38 Issue 4, p131
Stable angina pectoris is characterised by typical exertional chest pain that is relieved by rest or nitrates. Risk stratification of patients is important to define prognosis, to guide medical management and to select patients suitable for revascularisation. Medical treatment aims to relieve...
- Identification of Unstable Angina. // American Family Physician;11/15/1996, Vol. 54 Issue 7, p2307
Reports about the patients who suffered from unstable angina, a poorly defined state between stable angina and myocardial infarction. Classifications of patients with unstable angina; Treatment of patients who suffered from unstable angina; Difference in the treatment of patients in Great...
- Unstable angina: A comparison of medical and surgical treatment. // Modern Medicine;Feb95, Vol. 63 Issue 2, p48
Presents an abstract of the article `Identification of Unstable Angina Patients Who Have Unfavorable Outcome with Medical or Surgical Therapy (Eight-Year Follow-up of the Veterans Administration Cooperative Study),' by G.V.R. Sharma, R.H. Deupree, et al from the periodical `American Journal of...